2,010
Views
3
CrossRef citations to date
0
Altmetric
Article

Medical cannabis legalization and state-level prevalence of serious mental illness in the National Survey on Drug Use and Health (NSDUH) 2008–2015

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 203-215 | Received 22 Dec 2017, Accepted 16 Apr 2018, Published online: 16 Jul 2018

References

  • Andreasson, S., Allebeck, P., Engstrom, A., & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483–1486.10.1016/S0140-6736(87)92620-1
  • Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 325, 1212–1213. doi:10.1136/bmj.325.7374.1212
  • Baronet, A.-M. (1999). Factors associated with caregiver burden in mental illness: A critical review of the research literature. Clinical Psychology Review, 19, 819–841. doi:10.1016/S0272-7358(98)00076-2
  • Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., … Braithwaite, A. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117–1127. doi:10.1016/j.biopsych.2005.01.026
  • Cerda, M., Wall, M., Keyes, K. M., Galea, S., & Hasin, D. (2012). Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana use, abuse and dependence. Drug and Alcohol Dependence, 120, 22–27. doi:10.1016/j.drugalcdep.2011.06.011
  • Charara, R., El Bcheraoui, C., Kravitz, H., Dhingra, S. S., & Mokdad, A. H. (2016). Mental distress and functional health in the United States. Preventive Medicine, 89, 292–300. doi:10.1016/j.ypmed.2016.06.011
  • Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016). Marijuana use and use disorders in adults in the USA, 2002–14: Analysis of annual cross-sectional surveys. The Lancet Psychiatry, 3, 954–964. doi:10.1016/S2215-0366(16)30208-5
  • D'Addario, C., Micale, V., Di Bartolomeo, M., Stark, T., Pucci, M., Sulcova, A., … Dell'Osso, B. (2017). A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia. Schizophrenia Research, 188, 132–140. doi:10.1016/j.schres.2017.01.022
  • Dutra, L. M., & Glantz, S. A. (2017). E-cigarettes and national adolescent cigarette use: 2004-2014. Pediatrics, 139, e20162450. doi:10.1542/peds.2016-2450
  • Dutra, L. M., Glantz, S. A., Arrazola, R. A., & King, B. A. (2017). Impact of e-cigarette minimum legal sale age laws on current cigarette smoking. Journal of Adolescent Health, 62, 532–538. doi:10.1016/j.jadohealth.2017.11.302
  • Fernandez-Espejo, E., Viveros, M. P., Nunez, L., Ellenbroek, B. A., & Rodriguez de Fonseca, F. (2009). Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl), 206, 531–549. doi:10.1007/s00213-009-1612-6
  • First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J.B.W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York, NY: New York State Psychiatric Institute, Biometrics Research.
  • Gage, S. H., Hickman, M., & Zammit, S. (2016). Association Between Cannabis and Psychosis: Epidemiologic Evidence. Biological Psychiatry, 79, 549–556. doi:10.1016/j.biopsych.2015.08.001
  • Gilmer, T., & Kronick, R. (2011). Differences in the volume of services and prices drive big variations in Medicaid spending among US states and regions. Health Affairs, 30, 1316–1324. doi:10.1377/hlthaff.2011.0106
  • Guttmannova, K., Kosterman, R., White, H. R., Bailey, J. A., Lee, J. O., Epstein, M., … Hawkins, D. (2017). The association between regular marijuana use and adult mental health outcomes. Drug and Alcohol Dependence, 179, 109–116. doi:10.1016/j.drugalcdep.2017.06.016
  • Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74, 579–588. doi:10.1001/jamapsychiatry.2017.0724
  • Henry, J. Kaiser Family Foundation. (2018). State Mental Health Agency (SMHA) Per Capita Mental Health Services Expenditures. Retrieved 12 February 2018 from https://www.kff.org/other/state-indicator/smha-expenditures-per-capita/#note-2
  • Hoffmann, D. E., & Weber, E. (2010). Perspective: Medical marijuana and the law. New England Journal of Medicine, 362, 1453–1457. doi:10.1056/NEJMp1000695
  • Johnson, J., Hodgkin, D., & Harris, S. K. (2017). The design of medical marijuana laws and adolescent use and heavy use of marijuana. Analysis of 45 states from 1991 to 2011. Drug and Alcohol Dependence, 170, 1–8. doi:10.1016/j.drugalcdep.2016.10.028
  • Kamal, R. and Kaiser Family Foundation. (2017). What are the current costs and outcomes related to mental health and substance abuse disorders? Retrieved 20 March 2018 from: https://www.healthsystemtracker.org/chart-collection/current-costs-outcomes-related-mental-health-substance-abuse-disorders/#item-start
  • Kapur, S. (2003). Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. The American Journal of Psychiatry, 160, 13–23. doi:10.1176/appi.ajp.160.1.13
  • Karg, R. S., Bose, J., Batts, K. R., Forman-Hoffman, V. L., Liao, D., Hirsch, E., … Hedden, S. L. (2014). Past year mental disorders among adults in the United States: Results from the 2008–2012 Mental Health Surveillance Study. Rockville, MD: Substance Abuse and Mental Health Services Administration (US). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK379142/
  • Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., … Zaslavsky, A. M. (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60, 184–189. doi:10.1001/archpsyc.60.2.184
  • Lipari, R. N., Van Horn, S. L., Hughes, A., & Williams, M. (2017a). State and substate estimates of any mental illness from the 2012–2014 National Surveys on Drug Use and Health. Research Triangle Park, NC: RTI International.
  • Lipari, R. N., Van Horn, S. L., Hughes, A., & Williams, M. (2017b). State and substate estimates of serious mental illness from the 2012–2014 National Surveys on Drug Use and Health. Research Triangle Park, NC: RTI International.
  • Miller, R., Ream, G., McCormack, J., Gunduz-Bruce, H., Sevy, S., & Robinson, D. (2009). A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophrenia Research, 113, 138–144. doi:10.1016/j.schres.2009.04.018
  • Moore, H., West, A., & Grace, A. (1999). The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia. Biological Psychiatry, 46, 40–55. doi:10.1016/S0006-3223(99)00078-5
  • Moore, T.H.M., Zammit, S., Lingford-Hughes, A., Barnes, T.R.E., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370, 319–328. doi:10.1016/S0140-6736(07)61162-3
  • National Academies of Sciences Engineering and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. Retrieved from http://www.nap.edu/24625
  • National Alliance for Model State Drug Laws. (2017). Marijuana: Comparison of state laws allowing use for medicinal purposes. Retrieved 27 November 2017 from http://www.namsdl.org/library/5E330F37-EFA5-DDDE-0EF7018E59FC7C95/
  • National Conference of State Legislatures. (2018). State medical marijuana laws. Retrieved 20 March 2018 from http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
  • NORML. (2017). State Info. Retrieved 27 November 2017 from http://norml.org/states
  • Novak, S. (2007). An item response analysis of the World Health Organization Disability Assessment Schedule (WHODAS) items in the 2002-2004 NSDUH (prepared for the Substance Abuse and Mental Health Services Administration under Contract No. 283-03-9028, RTI/8726). Research Triangle Park, NC: RTI International.
  • Ojeda, V., & Bergstresser, S. (2008). Gender, race-ethnicity, and psychosocial barriers to mental health care: An examination of perceptions and attitudes among adults reporting unmet need. Journal of Health and Social Behavior, 49, 317–334. doi:10.1177/002214650804900306
  • Pacek, L. R., Mauro, P. M., & Martins, S. S. (2015). Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. Drug and Alcohol Dependence, 149, 232–244. doi:10.1016/j.drugalcdep.2015.02.009
  • Pacula, R. L., Hunt, P., & Boustead, A. (2014). Words can be deceiving: A review of variation among legally effective medical marijuana laws in the United States. Journal of Drug Policy Analysis, 7, 1–19. doi:10.1515/jdpa-2014-0001
  • Pacula, R. L., Powell, D., Heaton, P., & Sevigny, E. L. (2015). Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management, 34, 7–31. doi:10.1002/pam.21804
  • SAMHSA. (2013a). The NSDUH Report: revised estimates of mental illness from the National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH148/NSDUH148/sr148-mental-illness-estimates.htm#fn7
  • SAMHSA. (2013b). Results from the 2012 National Survey on Drug Use and Health: Mental health findings HHS Publication No. SMA 13-4805, NSDUH Series H-39. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • SAMHSA. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • SAMHSA. (2017). Population Data/NSDUH. Retrieved 27 November 2017 from https://www.samhsa.gov/data/population-data-nsduh/reports?tab= 33.
  • SAMHSA and HHS. (2016). Drug & Alcohol Services Information System Uniform Reporting Symptoms. Retrieved 2/12/2018 from https://wwwdasis.samhsa.gov/dasis2/urs.htm
  • SAMHSA, HHS, and RTI International. (2010). 2008–2010 National Survey on Drug Use and Health: Overview and summary of substate region estimation methodology: Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/sites/default/files/Substate2k10-Methodology/Methodology/NSDUHsubstateMethodology2010.pdf
  • SAMHSA, HHS, and RTI International. (2011). 2010-2011 National Survey on Drug Use and Health: Guide to State Tables and Summary of Small Area Estimation Methodology. Washington, DC: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUHsae2011-Methodology/NSDUHsae2011-Methodology/NSDUHsaeMethodology2011.pdf
  • SAMHSA, HHS, and RTI International. (2014). 2013-2014 National Survey on Drug Use and Health: Guide to State Tables and Summary of Small Area Estimation Methodology. Washington, DC: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUHsaeMethodology2014/NSDUHsaeMethodology2014.pdf
  • SAMHSA, HHS, and RTI International. (2015). 2014-2015 National Survey on Drug Use and Health: Guide to State Tables and Summary of Small Area Estimation Methodology. Washington, DC: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUHsaeMethodology2015/NSDUHsaeMethodology2015.pdf
  • Sherif, M., Radhakrishnan, R., D’souza, D. C., & Ranganathan, M. (2016). Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry, 79, 526–538. doi:10.1016/j.biopsych.2016.01.011
  • Song, A. V., Dutra, L. M., Neilands, T. B., & Glantz, S. A. (2015). Association of smoke-free laws with lower percentages of new and current smokers among adolescents and young adults: An 11-year longitudinal study. JAMA Pediatrics, 169, e152285. doi:10.1001/jamapediatrics.2015.2285
  • Stanley, T., & Doucouliagos, H. (2013). Meta-regression approximations to reduce publication selection bias. Research Synthesis Methods, 5, 60–78.doi:10.1002/jrsm.1095
  • United States Census Bureau. (2017a). American Community Survey. Retrieved 27 November 2017 from https://www.census.gov/programs-surveys/acs/
  • United States Census Bureau. (2017b). Health Insurance Historical Tables - HIC Series. Retrieved 19 March 2018 from https://www.census.gov/data/tables/time-series/demo/health-insurance/historical-series/hic.html
  • Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80. doi:10.1016/j.jhealeco.2015.03.007
  • Williams, A. R., Santaella-Tenorio, J., Mauro, C. M., Levin, F. R., & Martins, S. S. (2017). Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder. Addiction, 112, 1985–1991. doi:10.1111/add.13904

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.